Inventor · disambiguated record
Paul Glidden
Also filed as: GLIDDEN PAUL · GLIDDEN PAUL F
9 granted patents·18 pending applications·41 citations·filing 2004–2022
86Inventor score
Files withGLIDDEN PAUL14BIOVASCULAR INC5GLIDDEN PAUL F3CORINO THERAPEUTICS INC1LA JOLLA NANOMEDICAL INC1
Top patents by PatentIndex Score
27 records- 0186US11649259B2Polymorphic forms of deoxycytidine, compositions comprising the same and usesZOGENIX MDS INC·Filed 2020·Granted May 16, 2023·2 cites·27 claims
- 0286US7691839B2Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammationBIOVASCULAR INC·Filed 2006·Granted Apr 6, 2010·12 cites·3 claims
- 0385US9040483B2Controlled release compositions of agents that reduce circulating levels of platelets and methods thereforGLIDDEN PAUL F·Filed 2012·Granted May 26, 2015·8 cites·43 claims
- 0484US9750698B2Controlled release compositions of agents that reduce circulating levels of platelets and methods thereforBIOVASCULAR INC·Filed 2016·Granted Sep 5, 2017·4 cites·20 claims
- 0583US9381198B2Controlled release compositions of agents that reduce circulating levels of platelets and methods thereforBIOVASCULAR INC·Filed 2015·Granted Jul 5, 2016·4 cites·20 claims
- 0682US8282921B2tRNA synthetase fragmentsGLIDDEN PAUL·Filed 2009·Granted Oct 9, 2012·5 cites·7 claims
- 0781US8188034B2Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammationGLIDDEN PAUL F·Filed 2009·Granted May 29, 2012·6 cites·9 claims
- 0864US2009324710A1Controlled release compositions of agents that reduce circulating levels of platelets and methods thereforGLIDDEN PAUL F·Filed 2009·Application pending·0 cites
- 0962US12465615B2Aqueous solutions containing purines and pyrimidines and uses thereofUCB BIOSCIENCES INC·Filed 2022·Granted Nov 11, 2025·0 cites·34 claims
- 1057US2006078886A1Business methods for modulating angiogenesisGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 1157US2018153810A1Controlled release compositions of agents that reduce circulating levels of platelets and methods thereforBIOVASCULAR INC·Filed 2017·Application pending·0 cites
- 1251US2021069139A1Stabilization of transthyretin tetramers in biological fluidsCORINO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1351US2013108608A1tRNA synthetase fragmentsGLIDDEN PAUL·Filed 2012·Application pending·0 cites
- 1450US2006024286A1Variants of tRNA synthetase fragments and uses thereofGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 1550US2006079441A1Methods of modulating angiogenesisGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 1650US2006078553A1Diverse multi-unit complexes including a tRNA synthetase fragmentGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 1750US2006079672A1Kits for modulating angiogenesisGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 1850US2006079472A1Methods for treating angiogenesisGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 1950US2006024287A1Compositions and methods for modulating angiogenesisGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 2050US2006079473A1Multi-unit complexes and uses thereofGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 2148US2006078556A1Antibodies and epitopes specific to tRNA synthetase fragmentsGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 2247US9962443B2Cellular activity targeted nanoparticle system and methods of producing the nanoparticle systemLA JOLLA NANOMEDICAL INC·Filed 2016·Granted May 8, 2018·0 cites·20 claims
- 2347US2006079474A1Analogs of tRNA synthetase fragments and uses thereofGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 2442US2006024288A1tRNA synthetase fragmentsPFIZER·Filed 2005·Application pending·0 cites
- 2541US2006079673A1Polynucleotides encoding tRNA synthetase fragments and uses thereofGLIDDEN PAUL·Filed 2004·Application pending·0 cites
- 2639US2011034396A1Methods and compositions for inhibiting cell migration and treatment of inflammatory conditionsBIOVASCULAR INC·Filed 2010·Application pending·0 cites
- 2738US2006078887A1Methods for screening for anti-angiogenic agentsGLIDDEN PAUL·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →